| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $90K | — | — |
| R&D Expense | $4.2M | -12.9% | -56.5% |
| SG&A Expense | $1.5M | -41.5% | -45.7% |
| Operating Income | -$5.7M | +24.1% | +54.8% |
| Net Income | -$5.1M | +25.4% | +55.6% |
| EPS (Basic) | -$0.16 | +27.3% | +56.8% |
| EPS (Diluted) | -$0.16 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $53.4M | -10.9% | -32.1% |
| Current Assets | $54.4M | -10.9% | -31.6% |
| Total Assets | $56.2M | -10.9% | -31.6% |
| Current Liabilities | $6.8M | -17.8% | -11.9% |
| Total Liabilities | $42.4M | -3.7% | -3.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.3M | — | — |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$11K | — | — |
| Financing Cash Flow | -$214K | — | — |
| Free Cash Flow | -$19.3M | — | — |
| +56.8% |
| $13.8M |
| -27.5% |
| -63.9% |